Y Mabs Therapeutics Stock Analysis

YMAB Stock Analysis Notes

About 12.0% of the company outstanding shares are owned by insiders. The book value of Y MAbs was at this time reported as 2.05. The company has Price/Earnings To Growth (PEG) ratio of 0.04. Y mAbs Therapeutics recorded a loss per share of 0.67. The entity had not issued any dividends in recent years. Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York. Y-Mabs Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 148 people. For more information please call Michael Rossi at 646 885 8505 or visit https://www.ymabs.com.

Y mAbs Therapeutics Investment Alerts

Y mAbs Therapeutics Upcoming and Recent Events

YMAB Largest EPS Surprises

View All Earnings Estimates

Y MAbs Environmental, Social, and Governance (ESG) Scores

YMAB Stock Institutional Investors

Note, although Y MAbs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

YMAB Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 226.09 M.

YMAB Profitablity

The company has Profit Margin (PM) of (0.34) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.

Management Efficiency

Y mAbs Therapeutics has return on total asset (ROA) of (0.1267) % which means that it has lost $0.1267 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3074) %, meaning that it created substantial loss on money invested by shareholders. Y MAbs' management efficiency ratios could be used to measure how well Y MAbs manages its routine affairs as well as how well it operates its assets and liabilities. As of March 23, 2025, Return On Tangible Assets is expected to decline to -0.26. In addition to that, Return On Capital Employed is expected to decline to -0.34. At present, Y MAbs' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 129.5 M, whereas Other Assets are forecasted to decline to 1.09.

Technical Drivers

As of the 23rd of March, Y MAbs maintains the Market Risk Adjusted Performance of (0.65), mean deviation of 2.69, and Standard Deviation of 3.43. Compared to fundamental indicators, the technical analysis model lets you check practical technical drivers of Y mAbs Therapeutics, as well as the relationship between them.

Y mAbs Therapeutics Price Movement Analysis

Y mAbs Therapeutics Insider Trading Activities

Y MAbs Outstanding Bonds

Y MAbs Predictive Daily Indicators

Y MAbs Corporate Filings

Y MAbs Forecast Models

Y MAbs' time-series forecasting models are one of many Y MAbs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Y MAbs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Y MAbs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling YMAB shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Y MAbs. By using and applying YMAB Stock analysis, traders can create a robust methodology for identifying YMAB entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. YMAB analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. YMAB analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Y mAbs Therapeutics stock analysis indicators help investors evaluate how Y MAbs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Y MAbs shares will generate the highest return on investment. By understating and applying Y MAbs stock analysis, traders can identify Y MAbs position entry and exit signals to maximize returns.

When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.